Information Provided By:
Fly News Breaks for January 10, 2020
WCG, CHNG, ANTM, CNC, MCK
Jan 10, 2020 | 07:38 EDT
As previously reported, Morgan Stanley analyst Ricky Goldwasser upgraded McKesson (MCK) to Overweight from Equal Weight with a price target of $162, up from $135. Shares have underperformed the S&P in the last five years because of "a myriad of headwinds, with the most recent being concerns about opioids liability and its 2020/21 earnings power. However, Goldwasser believes specialty business and cost cutting initiatives can support earnings growth and exiting the investment in Change Healthcare (CHNG) should further strengthen McKesson's balance sheet, she tells investors. Her top picks in Healthcare Services for 2020 are Anthem (ANTM) and Centene (CNC). She sees the most multiple expansion opportunity for Anthem as it continues taking Medicare Advantage share and for Centene given its Wellcare (WCG) deal, said Goldwasser, who has a price targets of $382 for Anthem and $82 for Centene shares.
News For MCK;CNC;ANTM;CHNG;WCG From the Last 2 Days
ANTM
Jan 27, 2021 | 16:43 EDT
Equity futures were weaker in morning trading as worries over the virus, lockdowns and rocky vaccine rollouts all dampened risk appetite and the averages finished lower after the Fed ended its first policy meeting of the new year, even though the central bank committed to continue with its ultra-accommodative stance. Record revenues from... To see the rest of the story go to thefly.com. See Story Here
ANTM
Jan 27, 2021 | 13:13 EDT
Equity futures were weaker in morning trading as worries over the virus, lockdowns and rocky vaccine rollouts have all dampened risk appetite. Record revenues from... To see the rest of the story go to thefly.com. See Story Here
ANTM
Jan 27, 2021 | 09:08 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly.  HIGHER - Perspecta... To see the rest of the story go to thefly.com. See Story Here
ANTM
Jan 27, 2021 | 06:04 EST
On January 26, the Audit Committee, pursuant to authorization granted by the Board of Directors, authorized a $5B increase to the common stock repurchase program. The company intends to utilize this authorization over a multi-year period, subject to market and industry conditions.
ANTM
Jan 27, 2021 | 06:03 EST
Medical enrollment totaled approximately 42.9 million members at December 31, 2020, an increase of 1.9 million lives, or 4.7 percent from December 31, 2019. Total risk enrollment grew by 1.7 million lives, or 11 percent, and fee-based enrollment grew by 211 thousand lives, or 0.8 percent. Government Business enrollment increased by 1.9 million lives compared to the prior year, attributable to Medicaid, reflecting organic growth as a result of the temporary suspension of eligibility recertification efforts in our markets as well as our acquisition of the Medicaid plans in Missouri and Nebraska, and growth in Medicare Advantage. Commercial & Specialty Business enrollment increased by 67 thousand lives driven by the acquisition of AmeriBen and growth in our National business, partially offset by higher in-group change as a result of the economic environment. During the fourth quarter of 2020, medical enrollment increased sequentially by 300 thousand lives, reflecting organic growth in Medicaid and Medicare businesses as well as sales exceeding lapses in our Local Group business, partially offset by in-group change in the National business.
ANTM
Jan 26, 2021 | 14:01 EST
Notable companies reporting before tomorrow's open, with earnings consensus, include AT&T (T), consensus 73c... Abbott (ABT), consensus $1.35... Boeing (BA), consensus ($1.80)... Anthem (ANTM), consensus $2.52... Blackstone (BX), consensus 88c... ADP (ADP), consensus $1.29... Progressive (PGR), consensus $1.66... General Dynamics (GD), consensus $3.54... Amphenol (APH), consensus $1.02... V.F. Corp. (VFC), consensus 90c... Corning (GLW), consensus 48c... Textron (TXT), consensus 91c... Knight-Swift (KNX), consensus 91c... New York Community Bancorp (NYCB), consensus 26c... Brinker International (EAT), consensus 33c.
ANTM
Jan 26, 2021 | 07:34 EST
Cowen analyst Charles Ryhee raised the firm's price target on Anthem to $360 from $330 and keeps an Outperform rating on the shares. The analyst adjusted estimates ahead of earnings but will be focused on its comments on utilization Medicaid eligibility redeterminations and Commercial enrollment.